Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Amphetamine-Type Stimulants in a Group of Adults in Tehran, Iran: A Rapid Situation Assessment in Twenty-Two Districts

Roya Noori 1 , * , Reza Daneshmand 1 , Ali Farhoudian 1 , Salahedin Ghaderi 2 , Sepideh Aryanfard 3 and Afsaneh Moradi 4
Authors Information
1 Substance Abuse and Dependence Research Centre, University of Social Welfare and Rehabilitation Sciences, Tehran, IR Iran
2 Department of Sociology, Faculty of Humanities and Social Sciences, Kharazmi University, Tehran, IR Iran
3 Department of Social Welfare, University of Social Welfare and Rehabilitation Sciences, Tehran, IR Iran
4 Department of Psychology, School of Psychology and Educational Sciences, Al-Zahra University, Tehran, IR Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: December 2016, 10 (4); e7704
  • Published Online: October 3, 2016
  • Article Type: Original Article
  • Received: June 29, 2016
  • Revised: July 25, 2016
  • Accepted: September 22, 2016
  • DOI: 10.17795/ijpbs-7704

To Cite: Noori R, Daneshmand R, Farhoudian A, Ghaderi S, Aryanfard S, et al. Amphetamine-Type Stimulants in a Group of Adults in Tehran, Iran: A Rapid Situation Assessment in Twenty-Two Districts, Iran J Psychiatry Behav Sci. 2016 ; 10(4):e7704. doi: 10.17795/ijpbs-7704.

Copyright © 2016, Mazandaran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Alam-Mehrjerdi Z, Abdollahi M, Higgs P, Dolan K. Drug use treatment and harm reduction programs in Iran: A unique model of health in the most populated Persian Gulf country. Asian J Psychiatr. 2015; 16: 78-83[DOI][PubMed]
  • 2. Alam-mehrjerdi Z, Mokri A, Dolan K. Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country. Asian J Psychiatr. 2015; 16: 17-25[DOI][PubMed]
  • 3. Alam Mehrjerdi Z, Abarashi Z, Mansoori S, Deylamizadeh A, Salehi Fadardi J, Noroozi A, et al. Methamphetamine use among Iranian heroin kerack-dependent women: implications for treatment. Int J High Risk Behav Addict. 2013; 2(1): 15-21[DOI][PubMed]
  • 4. Alam Mehrjerdi Z. Crystal in Iran: methamphetamine or heroin kerack. Daru. 2013; 21(1): 22[DOI][PubMed]
  • 5. Djamshidian A. Neurobehavioral Sequelae of Psychostimulant Abuse. Int Rev Neurobiol. 2015; 120: 161-77[DOI][PubMed]
  • 6. Mehrjerdi ZA, Abarashi Z, Noroozi A, Arshad L, Zarghami M. Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran. Int J STD AIDS. 2014; 25(6): 420-7[DOI][PubMed]
  • 7. The guidelines for the development and implementation of drug abuse rapid situation assessments and responses.
  • 8. Diagnostic and statistical manual of mental disorders 2014;
  • 9. Baker A, Lee NK, Claire M, Lewin TJ, Grant T, Pohlman S, et al. Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction. Addiction. 2005; 100(3): 367-78[DOI][PubMed]
  • 10. Rawson RA, McCann MJ, Flammino F, Shoptaw S, Miotto K, Reiber C, et al. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction. 2006; 101(2): 267-74[DOI][PubMed]
  • 11. Shariatirad S, Maarefvand M, Ekhtiari H. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran. Int J Drug Policy. 2013; 24(6): 115-6[DOI][PubMed]
  • 12. Gonzales R, Ang A, Glik DC, Rawson RA, Lee S, Iguchi MY, et al. Quality of life among treatment seeking methamphetamine-dependent individuals. Am J Addict. 2011; 20(4): 366-72[DOI][PubMed]
  • 13. Lashkaripour K, Torbati E. Methamphetamine dependency. Int J High Risk Behav Addict. 2012; 1(1): 7-8[DOI]
  • 14. Radfar SR, Rawson RA. Current research on methamphetamine: epidemiology, medical and psychiatric effects, treatment and harm reduction efforts. Addict Health. 2014; 6(3-4): 146-54[DOI]
  • 15. Radfar SR, Cousins SJ, Shariatirad S, Noroozi A, Rawson RA. Methamphetamine use among patients undergoing methadone maintenance treatment in iran; a threat for harm reduction and treatment strategies: A qualitative study. Int J High Risk Behav Addict. 2016; : 30327[DOI]
  • 16. Behnoush B, Taghadosinejad F, Arefi M, Shahbai M, Jamalian M, Kazemifar AM. Prevalence and complications of drug-induced seizures in Baharloo hospital, Tehran, Iran. Iran J Toxicol. 2012; 6(6): 588-93
  • 17. Gonzales R, Mooney L, Rawson RA. The methamphetamine problem in the United States. Annu Rev Public Health. 2010; 31: 385-98[DOI][PubMed]
  • 18. Rawson RA, Anglin MD, Ling W. Will the methamphetamine problem go away? J Addict Dis. 2002; 21(1): 5-19[PubMed]
  • 19. Rawson RA, Gonzales R, Pearce V, Ang A, Marinelli-Casey P, Brummer J, et al. Methamphetamine dependence and human immunodeficiency virus risk behavior. J Subst Abuse Treat. 2008; 35(3): 279-84[DOI][PubMed]
  • 20. Porter J. The street/treatment barrier: treatment experiences of Puerto Rican injection drug users. Subst Use Misuse. 1999; 34(14): 1951-75[PubMed]
  • 21. Kenny P, Harney A, Lee NK, Pennay A. Treatment utilization and barriers to treatment: results of a survey of dependent methamphetamine users. Subst Abuse Treat Prev Policy. 2011; 14(6): 3[DOI]
  • 22. Kulesza M, Ramsey S, Brown R, Larimer M. Stigma among Individuals with Substance Use Disorders: Does it Predict Substance Use, and Does it Diminish with Treatment? J Addict Behav Ther Rehabil. 2014; 3(1): 1000115[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments